Oral Rehydration
Basics
Basics
Basics
Description
Description
Description
- Oral rehydration therapy (ORT) is a clinically useful, cost-effective, and safe technique to treat mild and moderate dehydration.
- ORT is as effective as IV hydration and the treatment of choice for mild to moderate dehydration.
- ORT can be divided into rehydration and maintenance phases.
- ORT should have an osmolality of ~245 mOsm/kg, a sodium (Na+) content of ~75 mEq/L, and a glucose concentration of ~75 mmol/L (13.5 g/L).
- Fruit juices, soda, popsicles, sports drinks, and broth often have inappropriate Na+ and/or electrolyte concentrations for isolated ORT.
- Although ORT can be prepared at home, commercially prepared solutions eliminate potential recipe errors.
- System(s) affected: endocrine/metabolic, gastrointestinal
Epidemiology
Epidemiology
Epidemiology
Incidence
- In 1980, diarrheal illness contributed to 4 to 6 million deaths annually in children age <5 years. By 2018, this declined to fewer than 500,000 annual deaths (despite a 70% increase in the world’s population).
- Acute diarrheal illness remains the second leading cause of mortality in children age <5 years in developing countries.
- Exercise-related dehydration is common (1).
Etiology and Pathophysiology
Etiology and Pathophysiology
Etiology and Pathophysiology
ORT takes advantage of the preserved coupled transport of Na+ and glucose in the small intestine during infectious gastroenteritis and exercise-associated dehydration. Water follows Na+ osmotically. Potassium is passively absorbed via solvent drag. An equimolar concentration of glucose and Na+ is most effective for ORT.
- Fluids with a higher ratio of glucose (juice, soda, sports drinks, etc.) have a high unabsorbed glucose load, which increases osmolality in the lumen, decreases water absorption, and increases diarrheal losses.
- Fluids with higher ratio of Na+ (chicken broth, etc.) lack enough solute for transport of Na+, leading to increased diarrheal losses (and potentially hypernatremia).
There's more to see -- the rest of this topic is available only to subscribers.
© 2000–2025 Unbound Medicine, Inc. All rights reserved